Novonix (NVX) Total Liabilities (2020 - 2025)

Novonix (NVX) has 6 years of Total Liabilities data on file, last reported at $121.2 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 37.0% year-over-year to $121.2 million; the trailing twelve-month figure through Dec 2025 stood at $121.2 million (up 37.0% YoY), and the FY2025 full-year result was $121.2 million, up 37.0% from the prior year.
• Total Liabilities for Q4 2025 stood at $121.2 million, up from $88.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $121.2 million in Q4 2025 and bottomed at $14.2 million in Q2 2021.
• The 5-year median for Total Liabilities is $66.6 million (2022), against an average of $68.1 million.
• The widest annual swing landed in 2022, when Total Liabilities surged 278.97%; it then increased 11.46% in 2024.
• A 5-year view of Total Liabilities shows it stood at $14.2 million in 2021, then surged by 261.33% to $51.4 million in 2022, then jumped by 54.58% to $79.4 million in 2023, then increased by 11.46% to $88.5 million in 2024, then jumped by 37.0% to $121.2 million in 2025.
• The last three Total Liabilities figures came in at $121.2 million (Q4 2025), $88.5 million (Q4 2024), and $79.4 million (Q4 2023), per Business Quant data.

Peer Comparison